Article
Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities
3 Mar 2021
Abstract excerpt
Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility. Clinical features of POF are hypoestrogenism or estrogen deficiency, increased gonadotropin level, and, most importantly, amenorrhea. With the development of regenerative medicine, human mesenchymal stem cell (hMSC) therapy brings new prospects for POF. This study aimed to describe the types of MSCs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
